Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Houssein Ayoub and Hiam Chemaitelly.
Houssein Ayoub
Connection Strength
1.765
Hiam Chemaitelly
  1. mRNA-1273 COVID-19 vaccine effectiveness against the B.1.1.7 and B.1.351 variants and severe COVID-19 disease in Qatar. Nat Med. 2021 09; 27(9):1614-1621.
    View in: PubMed
    Score: 0.239
  2. Epidemiological impact of prioritising SARS-CoV-2 vaccination by antibody status: mathematical modelling analyses. BMJ Innov. 2021 Apr; 7(2):327-336.
    View in: PubMed
    Score: 0.234
  3. Mathematical modeling of the SARS-CoV-2 epidemic in Qatar and its impact on the national response to COVID-19. J Glob Health. 2021 Jan 16; 11:05005.
    View in: PubMed
    Score: 0.231
  4. Characterizing key attributes of COVID-19 transmission dynamics in China's original outbreak: Model-based estimations. Glob Epidemiol. 2020 Nov; 2:100042.
    View in: PubMed
    Score: 0.228
  5. Age could be driving variable SARS-CoV-2 epidemic trajectories worldwide. PLoS One. 2020; 15(8):e0237959.
    View in: PubMed
    Score: 0.225
  6. Hepatitis C virus infection spontaneous clearance: Has it been underestimated? Int J Infect Dis. 2018 Oct; 75:60-66.
    View in: PubMed
    Score: 0.194
  7. Pfizer-BioNTech mRNA BNT162b2 Covid-19 vaccine protection against variants of concern after one versus two doses. J Travel Med. 2021 10 11; 28(7).
    View in: PubMed
    Score: 0.061
  8. Assessment of the Risk of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reinfection in an Intense Reexposure Setting. Clin Infect Dis. 2021 10 05; 73(7):e1830-e1840.
    View in: PubMed
    Score: 0.061
  9. Herd Immunity against Severe Acute Respiratory Syndrome Coronavirus 2 Infection in 10 Communities, Qatar. Emerg Infect Dis. 2021 05; 27(5):1343-1352.
    View in: PubMed
    Score: 0.059
  10. SARS-CoV-2 antibody-positivity protects against reinfection for at least seven months with 95% efficacy. EClinicalMedicine. 2021 May; 35:100861.
    View in: PubMed
    Score: 0.059
  11. Characterizing the Qatar advanced-phase SARS-CoV-2 epidemic. Sci Rep. 2021 03 18; 11(1):6233.
    View in: PubMed
    Score: 0.058
  12. Epidemiological Differences in the Impact of COVID-19 Vaccination in the United States and China. Vaccines (Basel). 2021 Mar 05; 9(3).
    View in: PubMed
    Score: 0.058
  13. Epidemiological Impact of SARS-CoV-2 Vaccination: Mathematical Modeling Analyses. Vaccines (Basel). 2020 Nov 09; 8(4).
    View in: PubMed
    Score: 0.057
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.